2002
DOI: 10.1164/ajrccm.165.4.2012112
|View full text |Cite
|
Sign up to set email alerts
|

Chemokine RANTES in Severe Pulmonary Arterial Hypertension

Abstract: The recent discovery that sporadic and familial primary pulmonary hypertension can be associated with germline mutations of genes encoding receptor members of the transforming growth factor-beta family has focused much attention on cytokines and growth factors in pulmonary vascular disorders. Production of several cytokines has been demonstrated in severe pulmonary arterial hypertension, emphasizing the possible influence of inflammatory mechanisms in this condition. Moreover, perivascular inflammatory cell in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
152
0
8

Year Published

2005
2005
2018
2018

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 243 publications
(172 citation statements)
references
References 44 publications
12
152
0
8
Order By: Relevance
“…The recognition of an inflammatory component in PH [16;74] supports the investigation of expression of cytokines that might potentially drive perivascular inflammation and thus contribute to the disease. Remodeled pulmonary arteries express IL-1, IL-6, and PDGF in infiltrating inflammatory cells [78;79], the chemokine RANTES (acronym for regulated upon activation, normal T-cell expressed and secreted), an important chemoattractant for monocytes and T cells [80], and the macrophage inflammatory protein-1α (MIP-1 α) [76]. Lungs of IPAH patients have increased expression of fractalkine, a chemokine involved in T cell trafficking and monocyte recruitment, and their circulating CD4 and CD8 T-cells have higher levels of the fractalkine receptor CX3CR1 when compared with controls or samples of patients with thromboembolic PH [81].…”
Section: Pathobiologymentioning
confidence: 99%
“…The recognition of an inflammatory component in PH [16;74] supports the investigation of expression of cytokines that might potentially drive perivascular inflammation and thus contribute to the disease. Remodeled pulmonary arteries express IL-1, IL-6, and PDGF in infiltrating inflammatory cells [78;79], the chemokine RANTES (acronym for regulated upon activation, normal T-cell expressed and secreted), an important chemoattractant for monocytes and T cells [80], and the macrophage inflammatory protein-1α (MIP-1 α) [76]. Lungs of IPAH patients have increased expression of fractalkine, a chemokine involved in T cell trafficking and monocyte recruitment, and their circulating CD4 and CD8 T-cells have higher levels of the fractalkine receptor CX3CR1 when compared with controls or samples of patients with thromboembolic PH [81].…”
Section: Pathobiologymentioning
confidence: 99%
“…Patients with underlying inflammatory and autoimmune diseases such as scleroderma (75), polyneuropathy, organomegaly, endocrinopathym M-protein, skin abnormalities (POEMS) syndrome (71), acquired immunodeficiency syndrome (21), sarcoidosis (94), and schistosomiasis (66) have a propensity to develop PH. Furthermore, patients with PH exhibit perivascular infiltrates of inflammatory cells (126), regulated on activation, normal T cell expressed and secreted (RANTES) associated with CD45 ϩ inflammatory cells (26), and increased circulating levels of proinflammatory cytokines such as IL-1, IL-6 (51), fractalkine (7), and monocyte chemoattractant protein-1, currently known as chemokine (C-C motif) ligand 2 (57).…”
Section: Endothelial Cell Functionmentioning
confidence: 99%
“…Lung tissue biopsy samples of patients with idiopathic pulmonary arterial hypertension (IPAH) demonstrate perivascular inflammatory cell infiltrates of T cells, B cells, and macrophages 20, 21. Circulating levels of serum cytokines including interleukin (IL)‐1β, IL‐2, IL‐4, IL‐6, IL‐8, IL‐10, IL‐12p70, and tumor necrosis factor α are significantly elevated when compared with controls 22, 23.…”
Section: Introductionmentioning
confidence: 99%